All Stories

  1. PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse

    Article • Current Neuropharmacology, August 2026, Bentham Science Publishers

    Prof. Abdalla Bowirrat, Alireza Sharafshah, Professor kenneth Blum, Rajendra Badgaiyan

  2. Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety

    Article • Current Pharmaceutical Biotechnology, March 2026, Bentham Science Publishers

    Prof. Abdalla Bowirrat, Professor kenneth Blum, Prof. Sergio Schmidt, Professor Aviv Weinstein, ROSSANO FIORELLI, Rajendra Badgaiyan, Alireza Sharafshah

  3. Why Psychiatric Drug Development Is Losing Momentum

    Article • Current Psychiatry Research and Reviews, February 2026, Bentham Science Publishers

    Rajendra Badgaiyan

  4. In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder

    Article • Current Neuropharmacology, July 2025, Bentham Science Publishers

    Alireza Sharafshah, Professor kenneth Blum, Prof. Sergio Schmidt, Rajendra Badgaiyan, ROSSANO FIORELLI, Prof. Abdalla Bowirrat

  5. Waiting for the Eureka Moment in Psychiatry Research

    Article • Current Psychiatry Research and Reviews, February 2025, Bentham Science Publishers

    Rajendra Badgaiyan

  6. Using science to fix addiction forever - Reward Deficiency Syndrome Solutions

    Article • Current Pharmaceutical Biotechnology, January 2024, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, ELIZABETH GILLEY, Prof. Abdalla Bowirrat

  7. Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression

    Article • Current Psychopharmacologye, April 2022, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Marjorie Gondre-Lewis, Prof. Abdalla Bowirrat

  8. Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic

    Article • Current Psychopharmacologye, June 2021, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Prof. Abdalla Bowirrat

  9. Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise

    Article • Current Psychopharmacologye, June 2021, Bentham Science Publishers

    Bernard Downs, Professor kenneth Blum, Rajendra Badgaiyan, DR DEBASIS BAGCHI

  10. Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.

    Article • Current Psychopharmacologye, June 2020, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan

  11. Hypodopaminergia and “Precision Behavioral Management” (PBM): It is a Generational Family Affair

    Article • Current Pharmaceutical Biotechnology, May 2020, Bentham Science Publishers

    Marjorie Gondre-Lewis, Professor kenneth Blum, Rajendra Badgaiyan, Bernard Downs

  12. The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Rajendra Badgaiyan, Professor kenneth Blum, Professor Zsolt Demetrovics

  13. Buprenorphine and Naloxone Combinations and Dopamine

    Article • Current Psychopharmacologye, January 2018, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Lyle Fried